Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015 (2015), Article ID 341362, 10 pages
http://dx.doi.org/10.1155/2015/341362
Review Article

Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer

Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo 160-0016, Japan

Received 26 September 2014; Accepted 13 January 2015

Academic Editor: Anish Bali

Copyright © 2015 Kouji Banno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Tsz-Lun Yeung, Cecilia S. Leung, Kay-Pong Yip, Chi Lam Au Yeung, Stephen T. C. Wong, and Samuel C. Mok, “Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: Cell and molecular processes in cancer metastasis,” American Journal of Physiology - Cell Physiology, vol. 309, no. 7, pp. C444–C456, 2015. View at Publisher · View at Google Scholar
  • Gordana Panic, Mireille Vargas, Ivan Scandale, and Jennifer Keiser, “Activity profile of an FDA-approved compound library against Schistosoma mansoni,” PLoS Neglected Tropical Diseases, vol. 9, no. 7, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  • Angiolo Gadducci, Nicoletta Biglia, Roberta Tana, Stefania Cosio, and Martina Gallo, “Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning,” Critical Reviews in Oncology/Hematology, 2016. View at Publisher · View at Google Scholar
  • Soojung Lee, Judee Grace E. Nemeño, and Jeong Ik Lee, “Repositioning Bevacizumab: A Promising Therapeutic Strategy for Cartilage Regeneration,” Tissue Engineering Part B: Reviews, 2016. View at Publisher · View at Google Scholar
  • You Hwa Son, Chi Hoon Park, and Sang Un Choi, “Identification of Mitotic Blockers by Phenotypic Screening of a Clinical Compound Library,” Bulletin of the Korean Chemical Society, vol. 37, no. 12, pp. 1942–1946, 2016. View at Publisher · View at Google Scholar
  • Friederike Hoellen, Martina Oberländer, Marc Thill, Maria Heide, Frank Köster, Maximilian Gebhard, Jens K. Habermann, Annika Waldmann, Constanze Banz-Jansen, Achim Rody, Julika Ribbat-Idel, and Christoph Thorns, “Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion,” Oncology Letters, vol. 12, no. 4, pp. 2351–2356, 2016. View at Publisher · View at Google Scholar
  • Alexandra Couttenier, Evelien Vaes, Chris R. Cardwell, Harlinde De Schutter, Olivia Lacroix, and Annie Robert, “Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study,” PLoS ONE, vol. 12, no. 12, 2017. View at Publisher · View at Google Scholar
  • E. Sahin, M. Eraslan Sahin, M. Dolanbay, B. Ozcelik, H. Akgun, and C. Saatci, “Induction of apoptosis by metformin and progesterone in estrogen-induced endometrial hyperplasia in rats: involvement of the bcl-2 family proteins,” Gynecological Endocrinology, pp. 1–4, 2017. View at Publisher · View at Google Scholar
  • Peng-Chen Chen, Yao Lin, and Xiaolong Liu, “Drug repurposing in anticancer reagent development,” Combinatorial Chemistry and High Throughput Screening, vol. 20, no. 5, pp. 395–402, 2017. View at Publisher · View at Google Scholar